AVEO
AVEO Pharmaceuticals, Inc.
AVEO
AVEO
Delisted
AVEO was delisted on the 19th of January, 2023.
52 hedge funds and large institutions have $92.7M invested in AVEO Pharmaceuticals, Inc. in 2021 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 14 increasing their positions, 14 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
48% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 23
Holders
52
Holding in Top 10
–
Calls
$3.37M
Puts
$2.32M
Top Buyers
| 1 | +$12.3M | |
| 2 | +$2.81M | |
| 3 | +$1.36M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$971K |
| 5 |
BGIM
Brandywine Global Investment Management
Philadelphia,
Pennsylvania
|
+$800K |
Top Sellers
| 1 | -$5.89M | |
| 2 | -$1.48M | |
| 3 | -$1.4M | |
| 4 |
MS
Maven Securities
St Helier,
Jersey
|
-$1.27M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$1.18M |